| Nanoparticles as vehicles for delivery of photodynamic therapy agents D Bechet, P Couleaud, C Frochot, ML Viriot, F Guillemin, ... Trends in biotechnology 26 (11), 612-621, 2008 | 944 | 2008 |
| Nanoparticles for radiation therapy enhancement: the key parameters P Retif, S Pinel, M Toussaint, C Frochot, R Chouikrat, T Bastogne, ... Theranostics 5 (9), 1030, 2015 | 363 | 2015 |
| Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity G Milano, MC Etienne, V Pierrefite, M Barberi-Heyob, R Deporte-Fety, ... British journal of cancer 79 (3), 627-630, 1999 | 339 | 1999 |
| Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy R Schneider, F Schmitt, C Frochot, Y Fort, N Lourette, F Guillemin, ... Bioorganic & medicinal chemistry 13 (8), 2799-2808, 2005 | 275 | 2005 |
| The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy L Sancey, F Lux, S Kotb, S Roux, S Dufort, A Bianchi, Y Cremillieux, ... The British journal of radiology 87 (1041), 20140134, 2014 | 239 | 2014 |
| Liposome encapsulation of curcumin: physico-chemical characterizations and effects on MCF7 cancer cell proliferation M Hasan, N Belhaj, H Benachour, M Barberi-Heyob, CJF Kahn, E Jabbari, ... International journal of pharmaceutics 461 (1-2), 519-528, 2014 | 235 | 2014 |
| Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy J Taquet, C Frochot, V Manneville, M Barberi-Heyob Current medicinal chemistry 14 (15), 1673-1687, 2007 | 208 | 2007 |
| A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells L Tirand, C Frochot, R Vanderesse, N Thomas, E Trinquet, S Pinel, ... Journal of Controlled Release 111 (1-2), 153-164, 2006 | 196 | 2006 |
| Improvement of meta-tetra(Hydroxyphenyl)chlorin-Like Photosensitizer Selectivity with Folate-Based Targeted Delivery. Synthesis and in Vivo Delivery Studies J Gravier, R Schneider, C Frochot, T Bastogne, F Schmitt, J Didelon, ... Journal of medicinal chemistry 51 (13), 3867-3877, 2008 | 169 | 2008 |
| AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine F Lux, VL Tran, E Thomas, S Dufort, F Rossetti, M Martini, C Truillet, ... The British journal of radiology 92 (1093), 20180365, 2019 | 159 | 2019 |
| Advantages and limitations of commonly used methods to assay the molecular permeability of gap junctional intercellular communication M Abbaci, M Barberi-Heyob, W Blondel, F Guillemin, J Didelon Biotechniques 45 (1), 33-62, 2008 | 159 | 2008 |
| Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies D Bechet, SR Mordon, F Guillemin, MA Barberi-Heyob Cancer treatment reviews 40 (2), 229-241, 2014 | 154 | 2014 |
| X-ray-induced singlet oxygen activation with nanoscintillator-coupled porphyrins AL Bulin, C Truillet, R Chouikrat, F Lux, C Frochot, D Amans, G Ledoux, ... The Journal of Physical Chemistry C 117 (41), 21583-21589, 2013 | 144 | 2013 |
| Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck … R Fety, F Rolland, M Barberi-Heyob, A Hardouin, L Campion, T Conroy, ... Clinical cancer research: an official journal of the American Association …, 1998 | 138 | 1998 |
| In vitro comparative evaluation of trastuzumab (Herceptin®) combined with paclitaxel (Taxol®) or docetaxel (Taxotere®) in HER2-expressing human breast cancer cell lines JL Merlin, M Barberi-Heyob, N Bachmann Annals of Oncology 13 (11), 1743-1748, 2002 | 120 | 2002 |
| Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity C Frochot, B Di Stasio, R Vanderesse, MJ Belgy, M Dodeller, F Guillemin, ... Bioorganic chemistry 35 (3), 205-220, 2007 | 117 | 2007 |
| Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status JF Mirjolet, M Barberi-Heyob, C Didelot, JP Peyrat, J Abecassis, R Millon, ... British journal of cancer 83 (10), 1380-1386, 2000 | 116 | 2000 |
| Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment S Pinel, N Thomas, C Boura, M Barberi-Heyob Advanced drug delivery reviews 138, 344-357, 2019 | 109 | 2019 |
| In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells P Mowat, A Mignot, W Rima, F Lux, O Tillement, C Roulin, M Dutreix, ... Journal of nanoscience and nanotechnology 11 (9), 7833-7839, 2011 | 107 | 2011 |
| The 2-aminoglucosamide motif improves cellular uptake and photodynamic activity of tetraphenylporphyrin B Di Stasio, C Frochot, D Dumas, P Even, J Zwier, A Müller, J Didelon, ... European journal of medicinal chemistry 40 (11), 1111-1122, 2005 | 103 | 2005 |
